TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 40 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 1,942,184 | $3,865,000 | 4.53% |
| NEA Management Company, LLC | 2,086,755 | $4,153,000 | 0.20% |
| BVF INC/IL | 150,000 | $299,000 | 0.05% |
| ABNER HERRMAN & BROCK LLC | 20,000 | $40,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 137,000 | $273,000 | 0.01% |
| Spark Investment Management LLC | 16,100 | $32,000 | 0.01% |
| CSS LLC/IL | 20,420 | $41,000 | 0.00% |
| Waverly Advisors, LLC | 2,670 | $5,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 134,293 | $267,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 466,573 | $928,000 | 0.00% |